Scientific Program

Print
Kindly click the lecture title to view the Speakers' Overviews of their Presentations

Thursday, February 19, 2015
Session 1
14:00-16:00
COMBINED HORMONAL CONTRACEPTION
The role of estrogens, progestins and androgens (Part 1)
Chairpersons: Sven Skouby, Denmark; Johannes Bitzer, Switzerland
14:00-14:30
14:30-15:00
15:00-15:30
15:30-16:00
Women using the pill miss/do not miss their androgens
Herjan Coelingh Bennink, The Netherlands
16:00-16:30
Coffee Break
Session 2
16:30-18:00
COMBINED HORMONAL CONTRACEPTION
The role of estrogens, progestins and androgens (Part 2)
Chairpersons: Lee Shulman, USA; Zeev Shoham, Israel
16:30-17:00
Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in contraception
Frank Stanczyk, USA
17:00-17:30
17:30-18:00
Hormonal contraception in patients with cardiac congenital malformations and valvular diseases
Joaquin Calaf Alsina, Spain
Session 3
18:00-18:45
PANEL DISCUSSION
Moderators: Michèle Lachowsky, France; Catelo Branco, Spain
18:00-18:15

Presenter:
Future contraception: what do women expect from hormonal contraception?

Christian Fiala, Austria

18:15-18:30 Presenter:
The pill today – stormy weather
Michèle Lachowsky, France
18:30-18:45 Panelists:
Paula Briggs, UK
Régine Sitruk-Ware, USA

Panel Topic:
Hormonal contraception: Empowerment of women?




Friday, February 20, 2015
Session 4
08:30-10:30
HORMONAL CONTRACEPTION:
Progestin only
Chairpersons: Ali Kubba, UK; Mary Short, Ireland
08:30-09:00
 
09:00-09:30
09:30-10:00
10:00-10:30
The optimal LARC
Ali Kubba, UK
10:30-11:00
Coffee Break
Session 5
11:00-12:30
NEW DEVELOPMENTS
Chairpersons: Christian Fiala, Austria; Johannes Bitzer, Switzerland
11:00-11:30
Lifelong fertility control and future population growth
David F. Archer, USA
11:30-12:00
12:00-12:30
12:30-13:30 Industrial Symposium
ESTETROL FOR ORAL CONTRACEPTION
Chairpersons: David Serfaty, France; Herjan Coelingh Bennink, The Netherlands
12:30-12:50 The fetal estrogen Estetrol (E4); is it a natural SERM?
Herjan Coelingh Bennink, The Netherlands
12:50-13:10 Detailed ovulation inhibition studies using E4 as the estrogen
Ingrid Duijkers, The Netherlands
13:10-13:30 The E4 oral contraceptive Fiesta study in Finland
Dan Apter, Finland
13:30-14:30
Break
Session 6
14:30-16:30
HORMONAL CONTRACEPTION: CONTROVERSIAL ISSUES
Chairpersons: Jeffrey Jensen, USA; Rik van Lunsen, The Netherlands
14:30-15:00
Hormonal contraception in PCOS. A risk or a benefit?
Sven Skouby, Denmark
15:00-15:30
Obesity and hormonal contraception
Gabriele Merki-Feld, Switzerland
15:30-16:00
16:00-16:30
16:30-17:00
Coffee Break
Session 7
17:00-18:00
PANEL DISCUSSION
Moderators: David Serfaty, France; Sven Skouby, Denmark
17:00-17:15 Presenter:
What is good clinical practice in counseling?
Johannes Bitzer, Switzerland
17:15-18:00

Panelists:
Gabriele Merki-Feld, Switzerland
Lee Shulman, USA

Panel Topics:
Best clinical practice in contraceptive counseling and care
MEC, EMA, FDA, Professional Societies

Saturday, February 21, 2015
Session 8
08:30-10:30
MEDICAL TERMINATION OF PREGNANCY AND EMERGENCY CONTRACEPTION
Chairpersons: Dan Apter, Finland; Zeev Shoham, Israel
08:30-09:00
Medical termination of pregnancy. An update
Kristina Gemzell-Danielsson, Sweden
 
09:00-09:30
Alternative Adolescence Contraception. A scientific review
Dan Apter, Finland
09:30-10:00
Should GnRH antagonists replace all other methods?
Zeev Shoham, Israel
10:00-10:30
10:30-11:00
Coffee Break
Session 9
11:00-12:30
MONITORING CLINICAL EFFECTS
Chairperson: Régine Sitruk-Ware, USA
11:00-11:30
11:30-12:00
Hormonal contraception and thrombosis: An update
Ojvind Lidegaard, Denmark
12:00-12:30
Hormonal contraception and thrombosis risk
Jacqueline Conard, France
Session 10
12:30-13:00
PANEL DISCUSSION:
Take-home messages
Moderators: David Serfaty, France; David F. Archer, USA
 
Panelists:
Sven Skouby, Denmark
Johannes Bitzer, Switzerland
Lee Shulman, USA
Zeev Shoham, Israel

Panel topics:
VTE risk
COC – non contraceptive benefits
Long cycle (COC, Ring, Patch)
Contraception in perimenopause
(Change to HRT?)
Bleeding problems